LPL Financial’s Precision BioSciences DTIL Stock Holding History

LPL Financial’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$71.7K	Sell	13,038 -1,003	-7%	-$4.63K	﹤0.01%	5730
2025 Q4	$58.4K	Buy	14,041 +2,000	+17%	+$11.4K	﹤0.01%	5684
2025 Q3	$66.5K	Sell	12,041 -1,400	-10%	-$6.7K	﹤0.01%	5594
2025 Q2	$56.5K	Buy	+13,441	New	+$66.3K	﹤0.01%	5349
2024 Q1	–	Sell	-622	Closed	-$6.81K	–	4949
2023 Q4	$6.81K	Sell	622 -847	-58%	-$9.13K	﹤0.01%	4767
2023 Q3	$15K	Buy	1,469 +30	+2%	+$461	﹤0.01%	4630
2023 Q2	$22.7K	Buy	1,439 +479	+50%	+$11K	﹤0.01%	4508
2023 Q1	$21.7K	Buy	960 +363	+61%	+$12K	﹤0.01%	4401
2022 Q4	$21.3K	Buy	+597	New	+$23.6K	﹤0.01%	4355

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LPL Financial's DTIL Position: Q1 2026 in Review

LPL Financial reduced its Precision BioSciences (DTIL) stake by 7.1% in Q1 2026, selling an estimated $4.63K and leaving 13,038 shares worth $71.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5730.

LPL Financial first reported a position in DTIL in Q4 2022 and has held it in 9 quarters since. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

LPL Financial held 13,038 shares of Precision BioSciences worth $71.7K as of Q1 2026.
LPL Financial sold 1,003 Precision BioSciences shares in Q1 2026, an estimated $4.63K.
Precision BioSciences made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5730 holding.
LPL Financial first reported a position in Precision BioSciences in Q4 2022 and has held it in 9 quarters since.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.